Form 4: CareDx Executive's Stock Transaction for Tax Withholding

CareDx Secretary and General Counsel Jeffrey Adam Novack disposed of 2,152 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Summary

• Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc. (CDNA), reported a transaction involving the company's common stock.
• On November 6, 2025, 2,152 shares of common stock were disposed of (withheld) by the Issuer.
• The shares were withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
• The price per share for the disposed securities was $15.01.
• Following this transaction, Jeffrey Adam Novack beneficially owns 107,906 shares of CareDx, Inc. common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction for tax withholding purposes, which is neutral in its impact on the company's fundamental outlook or investor sentiment.

Future Outlook

This Form 4 filing reports a routine insider transaction for tax purposes and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

SEC Form 4 filings provide transparency into insider transactions, which are routine for executives receiving equity compensation. This specific filing details a common practice where shares are withheld to cover tax liabilities upon the vesting of restricted stock units, a standard component of executive compensation packages in the biotechnology and healthcare diagnostics industry.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not a discretionary sale indicating a change in insider sentiment.
• Employees: Reflects standard equity compensation practices for executives.

Key Dates

Recommendation

This Form 4 filing details a routine tax-related disposition of shares by an executive, which is a common occurrence with equity compensation. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals.

Keywords

CareDx, CDNA, Form 4, Insider Transaction, Stock, Tax Withholding, Restricted Stock Units, RSU, Executive Compensation